There is no single best treatment for depression, but the strongest evidence points to a combination of talk therapy and, when needed, medication. What works best depends on how severe your symptoms are, how long you’ve had them, and how your body responds to treatment. The good news: several well-studied options exist, and if the first approach doesn’t work, alternatives often do.
Therapy Works as Well as Medication
Cognitive behavioral therapy (CBT) is the most studied form of talk therapy for depression, and its track record is strong. In a 10-year follow-up of a randomized controlled trial, 88% of participants who received CBT achieved remission from their depressive diagnoses, compared to 54% in a comparison group. People who responded well to CBT during the initial treatment phase were 7 to 9 times more likely to still be in remission a decade later. That lasting benefit is one of CBT’s biggest advantages: it teaches skills you keep using long after sessions end.
CBT works by helping you identify distorted thinking patterns and replace them with more realistic ones. Sessions are structured and goal-oriented, typically running 12 to 20 weeks. Other therapy types also have solid evidence behind them, including interpersonal therapy (which focuses on relationship conflicts and life transitions) and behavioral activation (which rebuilds routines and meaningful activities). The “best” therapy is often the one you’ll actually attend consistently.
Exercise Rivals Both Therapy and Medication
A large network meta-analysis published in the BMJ compared exercise head-to-head with other depression treatments. Walking or jogging produced a moderate reduction in symptoms (effect size of 0.62), which was actually larger than the effect size for CBT alone (0.55) and notably larger than SSRIs alone (0.26). These comparisons all used active controls like usual care or placebo tablets, so the differences reflect real-world impact.
This doesn’t mean you should skip medication in favor of a jog. Effect sizes from exercise studies can be inflated by factors like participant motivation and difficulty blinding people to whether they’re exercising. But the evidence is clear that regular physical activity, particularly aerobic exercise like brisk walking, running, or cycling, produces meaningful improvements in mood. For mild to moderate depression especially, exercise is a legitimate first-line treatment, not just a supplement.
How Antidepressant Medication Works
SSRIs are the most commonly prescribed antidepressants and remain the standard starting point for medication treatment. Five SSRIs are widely used, and they all work by increasing the availability of serotonin in the brain. The choice between them often comes down to side effect profile, potential drug interactions, and individual response. Doctors typically start at a low dose and adjust upward every two weeks or so until the medication reaches its therapeutic range.
One of the hardest parts of antidepressant treatment is the timeline. It takes several weeks, sometimes longer, before the full effect kicks in. Early side effects like nausea, sleep changes, or restlessness often show up before the mood benefits do, which can be discouraging. Many people stop too early because of this gap. If you’re starting medication, knowing about this delay ahead of time helps you stick with the process long enough to see results.
If an SSRI doesn’t work after an adequate trial (usually 6 to 8 weeks at a therapeutic dose), your prescriber may switch to a different SSRI, try an SNRI (which targets both serotonin and norepinephrine), or add a second medication to boost the first one’s effectiveness. Not responding to one antidepressant doesn’t mean medication won’t work for you. It often takes more than one attempt to find the right fit.
Genetic Testing Can Help Guide Prescribing
Pharmacogenomic testing analyzes how your genes affect the way you metabolize medications. In the GUIDED trial, patients whose prescribers used genetic test results to guide medication choices had significantly better outcomes than those receiving standard care. Remission rates were 18.2% versus 10.7%, and response rates were 27.0% versus 19.0% at eight weeks.
The benefit was most pronounced for people who switched medications based on test results: their remission rate was 20.3% compared to 11.1% for those in standard care. This type of testing is most useful if you’ve already tried one or two antidepressants without success. It won’t tell you which medication will definitely work, but it can rule out drugs your body processes too quickly or too slowly, narrowing the field.
Options for Treatment-Resistant Depression
When multiple rounds of medication and therapy haven’t produced adequate improvement, the diagnosis shifts to treatment-resistant depression, generally defined as failing to respond to two or more adequate medication trials. At this point, more intensive interventions become relevant.
Electroconvulsive therapy (ECT) is the oldest and most effective of these. Clinical trial data often cites remission rates of 70% to 90%, but real-world results are more modest. In a large community-based study of patients who had tried an average of 5.3 antidepressants before starting ECT, the remission rate was 31.4% and the response rate was 54.3%. Broader community hospital data shows remission rates between 30% and 47%. ECT is delivered under general anesthesia in a series of sessions, typically two to three times per week. Side effects can include short-term memory difficulties, though modern techniques have reduced this considerably.
Esketamine, a nasal spray derived from ketamine, is a newer option for treatment-resistant depression. Treatment involves an acute phase of twice-weekly sessions for four to eight weeks, followed by a maintenance phase that tapers from weekly to monthly over six to twelve months. In a real-world Israeli study, 48% to 60% of patients responded after the first month, with remission rates of 37% to 40%. Improvement during the maintenance phase was even higher, at 46.5%. Each session must be administered in a clinical setting because of monitoring requirements and potential side effects like dissociation and sedation.
Matching Treatment to Severity
For mild depression, structured exercise programs and therapy (particularly CBT or behavioral activation) are reasonable starting points. Many people with mild symptoms improve without medication, and starting with these approaches avoids potential side effects while building long-term coping skills.
Moderate depression typically benefits from therapy, medication, or both. Combining the two tends to produce better outcomes than either one alone, though starting with just one is perfectly reasonable, especially if you have a strong preference. If you start with therapy and don’t see meaningful improvement after 8 to 12 weeks, adding medication is a common next step, and vice versa.
Severe depression, especially when it involves significant functional impairment, weight changes, sleep disruption, or suicidal thoughts, generally calls for medication from the start, often alongside therapy. The worse the symptoms, the more important it becomes to use every effective tool available simultaneously rather than trying them one at a time.
What Recovery Actually Looks Like
Depression treatment isn’t a light switch. Most people experience gradual improvement over weeks to months rather than a sudden shift. With medication, sleep and energy often improve before mood does. With therapy, you may feel worse briefly as you start confronting difficult patterns before things get better. With exercise, consistency matters far more than intensity.
Remission, meaning your symptoms drop to a minimal level, is the goal, not just partial improvement. Stopping treatment too early is one of the most common reasons depression comes back. Current guidelines generally recommend continuing antidepressant medication for at least 6 to 12 months after you feel better, and longer if you’ve had multiple episodes. For therapy, the skills you learn persist, but periodic “booster” sessions can help during vulnerable periods.
The most important factor in finding the right treatment is honest communication about what’s working and what isn’t. If your current approach isn’t producing results after a reasonable trial, that’s not failure. It’s useful information that points toward the next step.